AGNG - Pockets Of Value In Stocks As Rates Rise

Summary

• We think value stocks can outperform as interest rates head higher. Regions and sectors help us find quality within value and growth at a reasonable price.
• Stocks slid after the Federal Reserve’s preferred inflation gauge showed persistently high inflation, reinforcing why we see more rate hikes ahead.
• We see a tight labor market in the euro area keeping core inflation elevated. China’s services PMI should show the economy's rapid restart is playing out.

Transcript

Growth stocks have led the equity rally this year, halting value stocks' 2022 outperformance. We think value can bounce back.

We have said this atypical economic cycle requires a new playbook. That’s true for us too when looking at equity style factors like value, growth and quality.

Investors define factors differently. We shape these preferences through sector and regional analysis.

1) Value versus growth amid rate hikes

Value’s underperformance is stark even with the surge last year as central banks rapidly hiked rates to fight inflation.

We seek value stocks with quality characteristics and would advocate for growth stocks at a reasonable price too.

2) The energy sector’s quality-value tilt

The energy sector is a great example of quality within value, thanks to recent capital discipline.

3) Value in the financial sector amid recession

We also find value in financials as the sector capitalizes on higher rates with higher interest income and margins after years of ultra-low or negative rates.

Recessions have historically been bad for capital-intensive value companies that can't respond quickly. But the mild recession we see ahead has been well-telegraphed, and value companies like banks have prepared for losses.

We expect higher policy rates for longer and see this weighing on growth stocks, but even here, we like growth sectors like healthcare.

In the short term, we prefer emerging market stocks to developed market peers given their value tilt.

___________

Growth stocks have led the U.S. equity rally so far this year, halting outperformance in 2022 by value equities. We believe value stocks can resume their climb as major central banks keep interest rates higher for longer. Higher rates reduce the value of future cash flows, weighing more on growth stocks and reinforcing our developed market equities underweight. Underneath that, our sector and region preferences tilt to value with quality attributes and growth at a reasonable price.

Value vs. growth

Notes: The chart shows the U.S. Russell 1000 Value total return index divided by the U.S. Russell 1000 Growth total return index.

The new regime is not a typical business cycle and requires a new playbook. That applies to equity style factors, too, in our view. Value stocks - or those seen as undervalued relative to fundamentals - lagged growth stocks for much of the past decade (left chart). That switched abruptly in 2022, when central banks started rapidly tightening policy - only to be followed by a value dip early this year on hopes for policy easing (right chart). We think value can regain the lead. Why? Higher interest rates and inflation, and a steeper yield curve. That all favors value over growth, in our view. It’s not about choosing one factor over another: factors mean different things to different people, and the composition of factors also changes over time. Case in point: the healthcare sector is now a modest overweight in the MSCI USA Value index, compared with an underweight in 2008.

Our macro view supports a case for value over growth. Higher interest rates feed into higher discount rates, making future cash flows of growth stocks less attractive. We also think persistent inflation is likely to lead investors to demand more compensation for holding long-term government bonds, driving yields higher. Value tends to outperform when the yield curve steepens, we find. While value historically underperforms heading into recession because capital-intensive companies can’t respond quickly to changing cycles, we think that could be different in this atypical economic cycle. Value is still attractive after being beaten down for so long. Companies in the value bucket have also had time to prepare for a well-telegraphed downturn. Case in point: many banks have already provisioned for losses in advance of a recession. Lastly, we expect a mild recession, so we think the performance impact is likely to be softer on value companies than in past cycles.

Getting granular

Our current asset allocations across regions and sectors have a value tilt with quality characteristics. We find that emerging markets ((EM)) and Europe have a consistent value bias when looking at the composition of indexes and key company metrics. For sectors, we see energy as a fusion of value and quality. We find value in the sector after being unloved and undisciplined with capital in the past. We think its stronger balance sheets, better investor payouts and improved return on equity give it more of a quality tilt. We find value in financials as well, but not the same quality. We see the sector capitalizing on higher rates with improved net interest margins after years of ultra-low or negative rates in some cases.

Healthcare has become more of a value sector but also has characteristics of growth. This speaks again to how factors can have different meanings and evolve over time. We like healthcare for its growth prospects but at the right price - valuations look reasonable to us relative to other growth sectors. We also see quality in healthcare’s defensive characteristics during a recession, and think aging populations bolster structural growth in demand.

Bottom line

We prefer to be selective within our cautious view of developed market ((DM)) equities. We like sectors and regions with a value bent, while we stay nimble in this new regime of heightened macro and market volatility. We think structurally higher inflation, higher-for-longer interest rates and our expectation for a steeper yield curve all favor value. We find value in the energy and financial sectors, and focus on quality within these sectors. We also like healthcare but at a reasonable price.

Market backdrop

Global stocks retreated further this week, with European equities faring better than U.S. peers. Short-term U.S. yields jumped to a 16-year high, with the yield curve at its most inverted since the early 1980s. The U.S. PCE inflation data showed stubbornly high core inflation. This reinforces our view that sticky inflation likely means major central banks will have to hike rates further and keep them higher for longer to bring it back down to their 2% targets.

Euro area inflation data this week will be key for gauging how much higher the European Central Bank might lift policy rates. We're also watching unemployment data for signs of further labor market tightness that could stoke persistently high core inflation. China’s services PMI will help assess how rapid the economy’s restart has been.

This post originally appeared on the iShares Market Insights.

For further details see: